Pfizer to Develop mRNA Vaccines Without BioNTech

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Mar 23, 2021 at 11:52 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via Pfizer's (NYSE: PFE) success in developing an effective COVID-19 vaccine in record time has given the pharmaceutical giant the confidence to invest heavily in the technology that underpins that vaccine. In an interview with The Wall Street Journal on Tuesday, CEO Albert Bourla revealed that Pfizer plans to become a leader in the development of new vaccines that rely on messenger RNA (mRNA).

    article source